학술논문

MIV-818 stimulates an antitumor immune response in vitro and enhances the effects of pembrolizumab
Document Type
Journal
Source
MOLECULAR CANCER THERAPEUTICS; DEC 2019, 18 12, 2p. Supplement: S
Subject
Language
English
ISSN
15388514